News and blogs
27 results found.
From despair to hope: The Matthew Wilson Multiple Myeloma Fund
Matthew Wilson establishes the Matthew Wilson Multiple Myeloma Fund (MWMMF) at Blood Cancer UK.
26th Jan 2024
What we can achieve with £1 million
We're proud to announce We’ve invested over £1 million funding five research projects, across five different blood cancers
4th Oct 2023
How we helped Covid booster vaccine research
Discover how Blood Cancer UK played a key part in Covid booster vaccine research for immune compromised patients, helping to create the OCTAVE-DUO study.
25th Aug 2021
Can a blood test detect cancer?
Learn more about a new blood test that looks at cell-free DNA (cfDNA) that could detect cancers earlier.
10th Aug 2021
Five reasons for people with blood cancer to be hopeful about the Covid pandemic
Find out why better treatments and vaccine efficacy should make people with blood cancer more hopeful about the Covid pandemic.
29th Jul 2021
Do people with myeloma have an antibody response to the Covid vaccine?
20th Apr 2021
How can I get involved in blood cancer research?
In November 2020, we asked our community to complete our survey and help us set our research priorities for the next five years.
24th Mar 2021
Covid vaccine: should people with blood cancer get an antibody test?
Here's what we think people with blood cancer should know about antibody tests, such as how they work and what the results might mean for you.
5th Mar 2021
From coronavirus to clinic: how did we get a vaccine?
We know a lot of people with blood cancer have questions on whether the coronavirus vaccine is safe after such a short amount of time. We hope to answer some of these questions by explaining how these vaccines have been developed.
11th Dec 2020
The coronavirus vaccine: what you need to know
We explain what we know about the potential vaccines and what they could mean for people with blood cancer.
25th Nov 2020
How does the coronavirus affect people with blood cancer?
We're funding vital research that will explore how different types of blood cancer might affect someone’s individual level of risk from coronavirus. This could lead to tailored advice for people with blood cancer during this pandemic.
11th Nov 2020
New research hope for those with a rare type of leukaemia
Our research fellow, Dr Marc Mansour and his team, have come to understand more about why some types of T-cell acute lymphoblastic leukaemia (T-ALL) stop responding to chemotherapy, and how we might overcome it in the future.
11th Jun 2020
What causes leukaemia and how can we use this information to better treat it?
2nd Feb 2020
How does the immune system recognise and destroy Hodgkin lymphoma?
In Hodgkin lymphoma, the cells which are the root cause of the cancer are hidden within a much larger number of white blood cells. These white blood cells are usually very good at killing cancer cells, but may be unable to kill all of the Hodgkin lymphoma cells. Bloodwise Visiting Fellow Dr Zumla Cader has been investigating why...
2nd Feb 2020
Researchers say blood cancer beaten in a few decades
Blood cancer researchers are excited about the future and say the scientific progress made mean blood cancer can be beaten in the next few decades.
2nd Feb 2020
How did a weapon of war become a blood cancer treatment?
As we pay tribute to the soldiers of World War I, we look at the surprising link between the battlefields of France and blood cancer research.
2nd Feb 2020
Blood cancer documentary gave me hope.
War in the Blood, a new BBC documentary follows two people who received CAR-T therapy, a groundbreaking new treatment for blood cancer, as part of a clinical trial. Kate, our Senior Support Services Manager, reviews the documentary.
8th Jul 2019
How to cope with stress: tips from Bloodwise researchers
For Mental Health Awareness Week, two Bloodwise-funded researchers share things they do to try to maintain mental wellbeing in a stressful environment.
13th May 2019
How a virus can lead to lymphoma
Some types of lymphoma are associated with high levels of a small piece of genetic material called microRNA-155. Professor Michelle West has been investigating how a virus that causes lymphoma increases the production of this cancer-driving microRNA.
17th Jan 2019
Blood Cancer UK research highlights 2018
From CAR-T therapy to a new understanding of how leukaemia develops in children. We look back at some of the breakthroughs our supporters help us fund.
21st Dec 2018